Therapeutic strategies for Parkinson's disease based on data derived from genetic research Olaf RiessDaniela BergJörg B. Schulz OriginalPaper Pages: i3 - i10
Differential diagnosis of parkinsonian syndromes: dynamics of time courses are essential L. Lachenmayer OriginalPaper Pages: i11 - i14
Functional imaging in Parkinson's disease: activation studies with PET, fMRI and SPECT Andres O. Ceballos-Baumann OriginalPaper Pages: i15 - i23
Does ultrasound disclose a vulnerability factor for Parkinson's disease? S. BehnkeD. BergG. Becker OriginalPaper Pages: i24 - i27
Autonomic dysfunctions in idiopathic Parkinson's disease Wolfgang H. Jost OriginalPaper Pages: i28 - i30
The relevance of preclinical studies for the treatment of Parkinson's disease M. GerlachP. FoleyP. Riederer OriginalPaper Pages: i31 - i34
Diffuse Lewy body disease – a clinical syndrome or a disease entity? Reiner Benecke OriginalPaper Pages: i39 - i42
Deep brain stimulation of the subthalamic nucleus for Parkinson's disease: a therapy approaching evidence-based standards G. DeuschlR. WenzelburgerJ. Volkmann OriginalPaper Pages: i43 - i46
Deep brain stimulation in dystonia Andreas KupschAndrea KuehnThomas Trottenberg OriginalPaper Pages: i47 - i52